\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\\	physical\\ examination\\ revealed\\ a\\ healthy\\ appearing\\ female\\ in\\ no\\ apparent\\ distress\\.\\ examination\\ of\\ the\\ lower\\ legs\\ revealed\\ large\\,\\ discrete\\,\\ irregularly\\ shaped\\ yellow\\ to\\ erythematous\\ plaques\\ on\\ the\\ anterior\\ and\\ medial\\ aspect\\ of\\ both\\ lower\\ legs\\.\\ the\\ plaques\\ were\\ markedly\\ indurated\\ and\\ covered\\ with\\ numerous\\ prominent\\ telangiectasias\\.\\ there\\ was\\ a\\ small\\ area\\ of\\ necrosis\\ with\\ focal\\ ulceration\\ on\\ the\\ inferior\\ aspect\\ of\\ the\\ lesion\\ on\\ the\\ left\\ leg\\.\\ there\\ was\\ no\\ palpable\\ regional\\ lymphadenopathy\\.\ \(0\)\
\-\ an\\ incisional\\ biopsy\\ was\\ performed\\ revealing\\ numerous\\ microcystic\\ spaces\\ in\\ the\\ deep\\ dermis\\ and\\ subcutaneous\\ fat\\ with\\ foreign\\ body\\ granulomatous\\ reaction\\,\\ foamy\\ histiocytic\\ infiltration\\,\\ stromal\\ hyalinization\\,\\ and\\ microcalcification\\ with\\ overlying\\ ulceration\\ consistent\\ with\\ silicone\\ granulomata\\.\ \(0\)\
\-\ the\\ patient\\ subsequently\\ underwent\\ excision\\ of\\ the\\ entire\\ lesion\\ on\\ the\\ left\\ lower\\ leg\\ with\\ placement\\ of\\ a\\ myocutaneous\\ free\\-flap\\ composed\\ of\\ latissimus\\ dorsi\\ and\\ split\\-thickness\\ skin\\ grafts\\.\\ she\\ tolerated\\ the\\ procedure\\ well\\ and\\ is\\ recovering\\ nicely\\.\ \(0\)\
\-\ silicone\\ granuloma\\ \\(1997\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ case\\#6\\)\\ presented\\ by\\:\\ lcdr\\ william\\ f\\.\\ smith\\,\\ mc\\,\\ usnr\ \(0\)\
\-\ the\\ patient\\ underwent\\ silicone\\ injections\\ of\\ both\\ lower\\ legs\\ in\\ the\\ early\\ 1960\\'s\\.\\ approximately\\ twenty\\ years\\ later\\ she\\ noted\\ progressive\\ scaling\\ and\\ erythema\\ in\\ the\\ injected\\ area\\,\\ and\\ subsequently\\ developed\\ firm\\,\\ slowly\\ enlarging\\ plaques\\ on\\ the\\ anterior\\ and\\ medial\\ aspect\\ of\\ both\\ lower\\ legs\\.\\ she\\ also\\ reported\\ pain\\ of\\ the\\ left\\ lower\\ extremity\\ with\\ ambulation\\.\\ pmhx\\:\\ significant\\ for\\ hypertension\\,\\ for\\ which\\ she\\ takes\\ zestril\\ 20\\ mg\\ per\\ day\\.\\ she\\ has\\ smoked\\ 1\\-2\\ ppd\\ of\\ cigarettes\\ for\\ greater\\ than\\ 30\\ years\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ legs\\:\\ 0\\.2602437727748118\ \(0\)\
\-\ silicone\\:\\ 0\\.22679820173010984\ \(0\)\
\-\ the\\:\\ 0\\.21116943469179128\ \(0\)\
\-\ lower\\:\\ 0\\.20279739920018347\ \(0\)\
\-\ plaques\\:\\ 0\\.20020068312824713\ \(0\)\
\-\ she\\:\\ 0\\.19686921405142674\ \(0\)\
\-\ ulceration\\:\\ 0\\.14452727984963687\ \(0\)\
\-\ of\\:\\ 0\\.14238459036337414\ \(0\)\
\-\ aspect\\:\\ 0\\.12801568538444186\ \(0\)\
\-\ and\\:\\ 0\\.1230103036552539\ \(0\)\
\-\ subsequently\\:\\ 0\\.11286651622296531\ \(0\)\
\-\ numerous\\:\\ 0\\.11174287613923384\ \(0\)\
\-\ both\\:\\ 0\\.11065513587338306\ \(0\)\
\-\ hyalinization\\:\\ 0\\.10577837477478137\ \(0\)\
\-\ zestril\\:\\ 0\\.10577837477478137\ \(0\)\
\-\ myocutaneous\\:\\ 0\\.10107688419591969\ \(0\)\
\-\ 1960\\:\\ 0\\.10107688419591969\ \(0\)\
\-\ on\\:\\ 0\\.09988285155311374\ \(0\)\
\-\ leg\\:\\ 0\\.09986520338209715\ \(0\)\
\-\ histiocytic\\:\\ 0\\.09774112354403483\ \(0\)\
\-\ scaling\\:\\ 0\\.09774112354403483\ \(0\)\
\-\ telangiectasias\\:\\ 0\\.09515370656718951\ \(0\)\
\-\ foamy\\:\\ 0\\.09515370656718951\ \(0\)\
\-\ microcalcification\\:\\ 0\\.09515370656718951\ \(0\)\
\-\ granulomata\\:\\ 0\\.09515370656718951\ \(0\)\
\-\ latissimus\\:\\ 0\\.09303963296517316\ \(0\)\
\-\ william\\:\\ 0\\.0912522092030781\ \(0\)\
\-\ underwent\\:\\ 0\\.09112893851146701\ \(0\)\
\-\ with\\:\\ 0\\.09066251416866503\ \(0\)\
\-\ incisional\\:\\ 0\\.08970387231328832\ \(0\)\
\-\ dorsi\\:\\ 0\\.08970387231328832\ \(0\)\
\-\ lcdr\\:\\ 0\\.08970387231328832\ \(0\)\
\-\ usnr\\:\\ 0\\.08970387231328832\ \(0\)\
\-\ cigarettes\\:\\ 0\\.08833814238631148\ \(0\)\
\-\ revealed\\:\\ 0\\.08674030205109794\ \(0\)\
\-\ medial\\:\\ 0\\.08610922623973717\ \(0\)\
\-\ smoked\\:\\ 0\\.08601130497095183\ \(0\)\
\-\ area\\:\\ 0\\.08569785217161374\ \(0\)\
\-\ examination\\:\\ 0\\.08465148198023009\ \(0\)\
\-\ indurated\\:\\ 0\\.08407426232659507\ \(0\)\
\-\ microcystic\\:\\ 0\\.08407426232659507\ \(0\)\
\-\ grafts\\:\\ 0\\.08407426232659507\ \(0\)\
\-\ recovering\\:\\ 0\\.08166662108254179\ \(0\)\
\-\ years\\:\\ 0\\.08109055856632674\ \(0\)\
\-\ nicely\\:\\ 0\\.0779740537402053\ \(0\)\
\-\ ambulation\\:\\ 0\\.0779740537402053\ \(0\)\
\-\ covered\\:\\ 0\\.0774586221068505\ \(0\)\
\-\ revealing\\:\\ 0\\.07517770674158504\ \(0\)\
\-\ ppd\\:\\ 0\\.07517770674158504\ \(0\)\
\-\ irregularly\\:\\ 0\\.07477081227349558\ \(0\)\
\-\ dermis\\:\\ 0\\.07477081227349558\ \(0\)\
\-\ twenty\\:\\ 0\\.07437771352683477\ \(0\)\
\-\ anterior\\:\\ 0\\.07386169282769899\ \(0\)\
\-\ regional\\:\\ 0\\.07362936985179526\ \(0\)\
\-\ tolerated\\:\\ 0\\.07362936985179526\ \(0\)\
\-\ injections\\:\\ 0\\.07292640902331138\ \(0\)\
\-\ yellow\\:\\ 0\\.0725902897647397\ \(0\)\
\-\ stromal\\:\\ 0\\.07226363992481843\ \(0\)\
\-\ injected\\:\\ 0\\.07226363992481843\ \(0\)\
\-\ composed\\:\\ 0\\.07194594053110998\ \(0\)\
\-\ takes\\:\\ 0\\.07194594053110998\ \(0\)\
\-\ physical\\:\\ 0\\.0717293999717617\ \(0\)\
\-\ pmhx\\:\\ 0\\.06993680250945877\ \(0\)\
\-\ mc\\:\\ 0\\.06942137087610398\ \(0\)\
\-\ was\\:\\ 0\\.06915533297826613\ \(0\)\
\-\ discrete\\:\\ 0\\.06845453589810459\ \(0\)\
\-\ left\\:\\ 0\\.06768930330399577\ \(0\)\
\-\ erythematous\\:\\ 0\\.06714045551083851\ \(0\)\
\-\ seminar\\:\\ 0\\.06653534591700193\ \(0\)\
\-\ uniformed\\:\\ 0\\.06596025438176455\ \(0\)\
\-\ in\\:\\ 0\\.06581774749001176\ \(0\)\
\-\ 1997\\:\\ 0\\.06541234288825667\ \(0\)\
\-\ smith\\:\\ 0\\.06541234288825667\ \(0\)\
\-\ infiltration\\:\\ 0\\.06523531193059709\ \(0\)\
\-\ slowly\\:\\ 0\\.06523531193059709\ \(0\)\
\-\ services\\:\\ 0\\.06488915779256485\ \(0\)\
\-\ dermatology\\:\\ 0\\.0647198802972423\ \(0\)\
\-\ lesion\\:\\ 0\\.06342164166118071\ \(0\)\
\-\ subcutaneous\\:\\ 0\\.0630047016442034\ \(0\)\
\-\ enlarging\\:\\ 0\\.061768529517506776\ \(0\)\
\-\ spaces\\:\\ 0\\.060187667213703167\ \(0\)\
\-\ entire\\:\\ 0\\.060187667213703167\ \(0\)\
\-\ for\\:\\ 0\\.06014305663268517\ \(0\)\
\-\ foreign\\:\\ 0\\.05996250863435548\ \(0\)\
\-\ firm\\:\\ 0\\.05996250863435548\ \(0\)\
\-\ granuloma\\:\\ 0\\.05985154795513149\ \(0\)\
\-\ erythema\\:\\ 0\\.05985154795513149\ \(0\)\
\-\ granulomatous\\:\\ 0\\.058796702668512106\ \(0\)\
\-\ markedly\\:\\ 0\\.0584002434516081\ \(0\)\
\-\ mg\\:\\ 0\\.05773747435311516\ \(0\)\
\-\ overlying\\:\\ 0\\.05635131216976245\ \(0\)\
\-\ reaction\\:\\ 0\\.056269941292018996\ \(0\)\
\-\ healthy\\:\\ 0\\.05610889283515717\ \(0\)\
\-\ apparent\\:\\ 0\\.05533558617417268\ \(0\)\
\-\ shaped\\:\\ 0\\.055261018055493806\ \(0\)\
\-\ per\\:\\ 0\\.05489520530440069\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.053473594293398735\ \(0\)\
\-\ distress\\:\\ 0\\.05328402109277158\ \(0\)\
\-\ appearing\\:\\ 0\\.05285337681144051\ \(0\)\
\-\ procedure\\:\\ 0\\.05273321716109306\ \(0\)\
\-\ there\\:\\ 0\\.05263684491002409\ \(0\)\
\-\ excision\\:\\ 0\\.05215041598295664\ \(0\)\
\-\ prominent\\:\\ 0\\.05209371512428428\ \(0\)\
\-\ placement\\:\\ 0\\.051649821590900764\ \(0\)\
\-\ deep\\:\\ 0\\.05148764688446369\ \(0\)\
\-\ progressive\\:\\ 0\\.050659058581255995\ \(0\)\
\-\ hypertension\\:\\ 0\\.05060918623558549\ \(0\)\
\-\ necrosis\\:\\ 0\\.05055952747663212\ \(0\)\
\-\ skin\\:\\ 0\\.049204814464966704\ \(0\)\
\-\ developed\\:\\ 0\\.04907329733678506\ \(0\)\
\-\ greater\\:\\ 0\\.048729707680128534\ \(0\)\
\-\ early\\:\\ 0\\.04767854285774984\ \(0\)\
\-\ reported\\:\\ 0\\.047639956124992146\ \(0\)\
\-\ extremity\\:\\ 0\\.047639956124992146\ \(0\)\
\-\ later\\:\\ 0\\.04733579960442905\ \(0\)\
\-\ palpable\\:\\ 0\\.046468456911893566\ \(0\)\
\-\ biopsy\\:\\ 0\\.04636446247048377\ \(0\)\
\-\ 30\\:\\ 0\\.04512208798873531\ \(0\)\
\-\ inferior\\:\\ 0\\.04499873254350694\ \(0\)\
\-\ body\\:\\ 0\\.043531199482410785\ \(0\)\
\-\ patient\\:\\ 0\\.043026531167113496\ \(0\)\
\-\ no\\:\\ 0\\.043018438127427124\ \(0\)\
\-\ 20\\:\\ 0\\.042671895128147286\ \(0\)\
\-\ approximately\\:\\ 0\\.04220457685217715\ \(0\)\
\-\ day\\:\\ 0\\.042132481474882695\ \(0\)\
\-\ fat\\:\\ 0\\.04114553986104108\ \(0\)\
\-\ focal\\:\\ 0\\.03956424614425285\ \(0\)\
\-\ performed\\:\\ 0\\.03913090252579712\ \(0\)\
\-\ presented\\:\\ 0\\.038571331887894536\ \(0\)\
\-\ significant\\:\\ 0\\.03818998712347992\ \(0\)\
\-\ than\\:\\ 0\\.037495053503688376\ \(0\)\
\-\ consistent\\:\\ 0\\.03586469998588085\ \(0\)\
\-\ noted\\:\\ 0\\.035069358848421855\ \(0\)\
\-\ small\\:\\ 0\\.034119212264045955\ \(0\)\
\-\ were\\:\\ 0\\.03409523024413617\ \(0\)\
\-\ exam\\:\\ 0\\.03329683428849621\ \(0\)\
\-\ case\\:\\ 0\\.033229938127026994\ \(0\)\
\-\ large\\:\\ 0\\.03314133939611931\ \(0\)\
\-\ well\\:\\ 0\\.03202716583857395\ \(0\)\
\-\ female\\:\\ 0\\.03191744602857828\ \(0\)\
\-\ also\\:\\ 0\\.031112159363613737\ \(0\)\
\-\ has\\:\\ 0\\.03021257171843839\ \(0\)\
\-\ which\\:\\ 0\\.03007625505669205\ \(0\)\
\-\ by\\:\\ 0\\.028088504011579883\ \(0\)\
\-\ an\\:\\ 0\\.025293176425021734\ \(0\)\
\-\ pain\\:\\ 0\\.023668694551425163\ \(0\)\
\-\ is\\:\\ 0\\.018113935694694997\ \(0\)\
\-\ to\\:\\ 0\\.016535826174687882\ \(0\)\
